OxygenCare launches GE Carestation 850 Anaesthesia System at CAI Congress
OxygenCare has announced the Irish launch of the GE Carestation 850 Anaesthesia Delivery System at the College of Anaesthesiologists of Ireland Annual Congress.
Read moreOxygenCare has announced the Irish launch of the GE Carestation 850 Anaesthesia Delivery System at the College of Anaesthesiologists of Ireland Annual Congress.
Read morePresented at the All-Island Cancer Summit, the Cancer Dashboard for Ireland report outlines growing pressures on Ireland’s cancer system and identifies key priorities for the next National Cancer Strategy.
Read moreGilead Sciences and Kite have announced the reimbursement of two CAR T-cell therapies in Ireland for eligible adult patients with certain relapsed or refractory blood cancers.
Read moreThe European Commission has approved AKEEGA® (niraparib and abiraterone acetate) for patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer, following Phase 3 data showing a significant delay in disease progression and an early survival benefit.
Read moreThe Irish Cancer Society provided almost 30,000 free lifts to and from cancer treatment in 2025, alongside thousands of counselling sessions, support line conversations, and nights of end-of-life nursing care, according to new figures released ahead of Daffodil Day.
Read moreHPV Network Ireland has launched on International HPV Awareness Day, bringing together health and advocacy organisations to strengthen awareness of HPV and the cancers it can cause.
Read moreResearchers from across Ireland were honoured at the Irish Cancer Society Research Awards 2026, recognising advances in radiotherapy innovation and men’s cancer survivorship care.
Read moreBeacon Hospital has marked a major milestone with the first brick laid on its €100m eight-storey expansion, which will add 70 new beds and a new Emergency Department.
Read morePADCEV (enfortumab vedotin) plus Keytruda has demonstrated significant improvements in event-free and overall survival in patients with muscle-invasive bladder cancer, regardless of cisplatin eligibility.
Read moreBeacon Hospital has treated the first patient in Ireland and the UK using RapidArc Dynamic radiotherapy technology. Delivered through the Varian TrueBeam system, the platform offers exceptional precision, faster planning and treatment times, and greater protection of healthy tissue in cancer care.
Read more